Diss. (sammanfattning) Stockholm : Karol. inst., 2005. / Härtill 5 uppsatser.

Dissertation (Ph.D.).--University of Texas Graduate School of Biomedical Sciences at San Antonio, 2007. / Vita. Includes bibliographical references.

Orientador: Marcio Ajudarte Lopes / Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba / Made available in DSpace on 2018-08-15T17:55:17Z (GMT). No. of bitstreams: 1 Santos-Silva_AlanRoger_D.pdf: 1071923 bytes, checksum: 996d56a5e4895653ebcd0b9e1636e7e2 (MD5) Previous issue date: 2010 / Resumo: Predominantemente, o carcinoma espinocelular (CEC) de boca afeta pacientes idosos e com frequência se desenvolve em associação com o consumo de fumo e álcool. Todavia, evidências científicas têm sugerido o aumento da incidência desta malignidade em pacientes com menos de 40 anos de idade e não expostos aos tradicionais fatores de risco. Informações disponíveis referentes ao câncer de boca em pacientes jovens são escassas e controversas, dificultando a compreensão da patogênese, do comportamento biológico e do prognóstico destes tumores. Como consequência, seu tratamento tem sido baseado principalmente na experiência profissional de cada centro médico. Este trabalho teve como objetivos estudar as características demográficas, os fatores de risco e os aspectos clínicos no momento do diagnóstico, além do perfil biológico de CECs de língua em pacientes com até 40 anos. Foi realizada uma análise retrospectiva multiinstitucional a fim de se investigar gênero, cor da pele, consumo de tabaco e álcool, tamanho dos tumores, metástase regional e à distância, diferenciação histológica e ploidia do DNA dos tumores por meio de citometria por imagem. Os resultados mostraram que tumores em pacientes jovens foram frequentemente detectados em mulheres e pacientes não fumantes e não etilistas, enquanto em pacientes idosos foram detectados, predominantemente, em homens fumantes e etilistas. Além disso, constatou-se que CECs de língua em jovens não se distinguem quanto ao tamanho, a metástases regionais ou à distância e nem quanto ao grau de diferenciação histológica quando comparados com idosos. Ressalta-se, entretanto, que tumores em jovens apresentaram maiores incidências de aneuploidia, tetraploidia e de outros parâmetros de anormalidades da ploidia do DNA. Concluindo, pacientes jovens com CEC de língua apresentaram perfil clínico e biológico peculiares, favorecendo a hipótese de que pacientes jovens com CEC de boca possuem instabilidade genômica aumentada e indicando uma possível natureza genética diferente entre os CECs de língua de jovens e de idosos / Abstract: Oral squamous cell carcinoma (SCC) predominately affects elderly patients and frequently develops in association with tobacco and alcohol consumption. However, an increasing of this malignant disease has been observed in patients younger than 40 years of age, who are not exposed to the traditional risk factors. Data regarding oral cancer in young patients are scarce and controversial, making the determination of the pathogenesis, biological behaviour and prognosis of these tumours difficult. As a consequence, treatment has been mainly based on the professional experience of each medical centre. The aims of this work were to study demographic features, risk factors and clinical aspects at the moment of diagnosis as well as the biologic profile of patients of less than 40 years of age with tongue SCC. A multi-centre retrospective analysis was performed to investigate gender, race, tobacco consumption and alcohol intake, size of the tumour, regional and distant metastasis, histological differentiation and DNA ploidy of tumours through image cytometry. Tumours in young patients were frequently detected in females and nonsmoking and non-drinking patients while older patients were predominantly smoking and drinking males. In addition, tongue SCC in young patients did not differ in size, regional and distant metastasis or tumour grade of differentiation when compared to those in older patients. This study highlighted that tumours from young patients presented higher incidences of aneuploidy, tetraploidy and other parameters related to DNA ploidy abnormalities. In conclusion, young patients with tongue SCC presented a distinct clinical and biological profile, favouring the hypothesis that young patients with oral SCC may have an increased genomic instability and indicating the possibility of underlying genetic differences between TSCC in young and older patients / Doutorado / Patologia / Doutor em Estomatopatologia

Oxidative stress (OS) occurs when DNA repair mechanisms are overcome by the amount of single and double strand DNA breaks caused by an accumulation of reactive oxygen species (ROS). Genomic instability (GI) by microsatellite instability (MSI) accumulation is characterized by changes in DNA single tandem repeats (STR) as a direct result of ROS. Deregulation of DNA repair and tumor suppressor pathways have been described as causes of tumor progression and metastasis. Studies in mammals have focused on GI and the implications of increased mutation frequency due to accumulation of MSI leading to development of diseases, including infertility and cancer. Ovarian cancer is a deadly disease displaying the highest mortality rate among gynecological cancers. Hereditary ovarian cancer displays GI that can be established early in primordial germinal cells (PCGs) development and migration across the genital ridge, where PGCs are exposed to ROS damage. The hypothesis of this study was ROS-induced GI is marked by the accumulation of MSI on repetitive sequences of DNA that override DNA repair, tumor suppressor and redox homeostasis pathways. In this study, we induced ROS in human ovarian cell lines by hydrogen peroxide (H2O2) exposure, as well as evaluated mouse PGCs to determine whether MSI occurs in specific regions of human and mouse genomes. Our results show that MSI was present in specific markers after ROS-induced damage in human ovarian cells and in mouse Sod1 knockout PGCs during cell migration, both of which accumulate specific mutations caused by free radical damage. Ovarian tumor cells and mouse PGCs showed an increase of MSI in 12 human and 5 mouse repetitive markers that are located near important genes related to DNA repair, tumor suppression, cell proliferation, apoptosis and differentiation. This could be a signal that leads to tumor initiation, formation and progression in adult ovarian cells due to improper DNA repair and tumor suppression mechanisms or in disruption of PGC migration that determines germinal cell pool selection during early embryonic development due to absence of cell antioxidant mechanisms. Therefore, these specific unstable STRs are novel biomarkers that could be useful in early diagnostics, prognosis, and successful therapy of ovarian tumorigenesis.

Yes / Cancer-causing mutations often arise from inappropriate DNA repair, yet acute exposure to DNA damage is widely used to treat cancer. The challenge remains in how to specifically induce excessive DNA damage in cancer cells while minimizing the undesirable effects of genomic instability in noncancerous cells. One approach is the acute exposure to hyperthermia, which suppresses DNA repair and synergizes with radiotherapy and chemotherapy. An exception, however, is the protective effect of hyperthermia on topoisomerase targeting therapeutics. The molecular explanation for this conundrum remains unclear. Here, we show that hyperthermia suppresses the level of topoisomerase mediated single- and double-strand breaks induced by exposure to topoisomerase poisons. We further uncover that, hyperthermia suppresses hallmarks of genomic instability induced by topoisomerase targeting therapeutics by inhibiting nuclease activities, thereby channeling repair to error-free pathways driven by tyrosyl-DNA phosphodiesterases. These findings provide an explanation for the protective effect of hyperthermia from topoisomerase-induced DNA damage and may help to explain the inverse relationship between cancer incidence and temperature. They also pave the way for the use of controlled heat as a therapeutic adjunct to topoisomerase targeting therapeutics.

No description available.

Optimizing culture conditions that reduce genomic instability in human pluripotent stem cells (hPSCs) is an unmet challenge in the field. Results from our lab and numerous research groups demonstrate that hPSCs are prone to genomic aberrations and single-cell passaging increases the rate of genomic alterations. However, single-cell based passaging maintains advantages for scale-up and standardizing differentiation protocols. In this study, we investigated the problem of genomic instability in hPSC cultures with the goal towards identifying and characterizing candidate genes that could contribute to generation and survival of abnormal hPSCs. Based on microarray analysis, we identify ARHGDIA, located on 17q25, as a candidate gene conferring selective advantage to trisomy 17 hPSCs. Using lentiviral approaches to overexpress ARHGDIA in hPSCs, [hPSC (Arg)], we functionally validate that in enzymatically passaged co-cultures, hPSC (Arg) lines exhibit competitive advantage against wild type hPSCs, [hPSC (WT)]. Additionally, hPSC (Arg) lines exhibit increased single-cell survival at low density plating. In co-cultures with hPSC (WT), ROCKi exposure attenuated the competitive advantage of hPSC (Arg) subpopulations. For the first time, this work demonstrates that increased expression of a gene on 17q25 confers selective advantage to hPSCs. In parallel studies, using medium devoid of bFGF containing LIF plus two inhibitors, MEK inhibitor (PD0325901) and p38 inhibitor (SB203580), we demonstrate that hPSCs are LIF responsive and can be stably maintained in naive pluripotent culture conditions. Based on their clonal viability, we propose that naive hPSCs are a more genetically stable population than primed hPSCs, when passaged as single- cells. These studies will aid the long-term goal of hPSC scale-up while promoting stable propagation of genomically normal hPSCs.

Investigating the biological basis of ageing is both fascinating and medically relevant, as we strive to understand both how organisms age, and how our knowledge might be put to good use in an increasingly long-lived human population. Despite the complexity of ageing biology, it is very striking that longevity, in a wide variety of organisms, can be modified by manipulating single genes. In this thesis, I investigate phenotypes associated with mutations in C. elegans homologues of human WRN, the gene mutated in the progeroid Werner syndrome (WS). Mutant phenotypes in the worm recapitulate aspects of the pathophysiology observed in WS patients, including premature ageing, genomic instability, and sensitivity to DNA damaging agents. wrn-1 overexpression, on the other hand, appears to enhance longevity, suggesting that wrn-1 acts as a bona fide anti-gerontogene. The combination of wrn-1 mutations with mutation in the worm p53 homologue, cep-1, unexpectedly triggers a novel and very striking enhanced lifespan and healthspan phenotype, termed synthetic super-viability (SSV). The SSV phenotype is modulated by various environmental inputs such as temperature stress. The data presented here can be incorporated into a model in which stress sensing (involving p53) is the crucial determinant of longevity outcomes. Several theories of ageing incorporate the idea that 'that which does not kill us, makes us stronger' - encapsulated in a biological sense in the idea of hormesis, a physiological shift in response to stress. Here, this hypothesis is expanded to include the notion that intrinsic <strong>responses</strong> to stress may themselves act to limit lifespan - too much of a good thing can be bad.

La réplication de l’ADN est un phénomène physiologique essentiel à la transmission du patrimoine génétique mais est aussi une source importante de stress endogène. Le stress réplicatif peut conduire à une instabilité génomique et a été mis en évidence à une étape très précoce du développement tumoral et de la sénescence. La recombinaison homologue (RH) est un processus de réparation qui permet la prise en prise en charge du stress réplicatif. De ce fait, un défaut de RH devrait permettre de révéler les stress réplicatifs endogènes. Ainsi, une progression ralentie des fourches de réplication a été observée dans des cellules déficientes pour la RH (RH-), et ce en absence de tout traitement exogène (Daboussi 2008). De plus, de nombreux travaux ont mis en évidence la présence de défauts mitotiques dans les cellules RH-, en absence de tout traitement exogène (Griffin 2000; Kraakman-van der Zwet 2002; Bertrand 2003; Daboussi 2005; Laulier 2011; Rodrigue 2013). L’origine de ces défauts mitotiques spontanés reste peu claire. En effet, la RH étant un processus préférentiellement actif au cours des phases S et G2, le lien avec la mitose reste à éclaircir. Cette thèse a pour but de comprendre l’impact du stress réplicatif très faible ou endogène sur les phases post-réplicatives du cycle cellulaire. Dans un premier temps, je me suis intéressée à l’impact de ce stress sur la mitose. Les résultats obtenus montrent que le traitement des cellules contrôle à de très faibles doses d’hydroxyurée (HU) n’affecte pas la progression dans le cycle cellulaire mais induit cependant une diminution de la vitesse de réplication, comparable à celle observée dans les cellules RH-. De plus le traitement des cellules contrôle à des faibles doses d’HU induit l’apparition de défauts mitotiques, notamment des centrosomes surnuméraires, à la même fréquence que dans les cellules RH- non traitées. Inversement, l’ajout de précurseurs de nucléotides dans les cellules RH- permet de supprimer la diminution de la vitesse de réplication ainsi que les centrosomes mitotiques surnuméraires. Ainsi, un stress réplicatif subtil, qui n’impacte pas de façon détectable la progression dans les phases S et G2 du cycle cellulaire, ni l’entrée en mitose, cause cependant des défauts mitotiques sévères. De façon importante, les centrosomes mitotiques surnuméraires peuvent entrainer des mitoses multipolaires, impactant ainsi l’ensemble du génome. Ces données mettent en évidence la connexion qui existe entre la réplication des chromosomes et leur ségrégation. Dans un second temps, j’ai étudié l’impact du stress réplicatif faible ou endogène en phase G2. Cette étude a été réalisée en utilisant des cellules RH-, ainsi qu’un modèle d’induction de faible stress réplicatif après traitement à très faible dose d’HU. La présence de foyers pRPA-Ser33 en phase G2 a été observée dans ces deux modèles, mettant en évidence des zones de stress réplicatif. Après traitement à très faible dose d’HU, nous observons également la présence en phase G2 de foyers 53BP1 et RAD51 qui colocalisent partiellement avec les foyers pRPA-Ser33. L’analyse en spectrométrie de masse après co-immunoprécipitation de la protéine 53BP1 en phase G2 a permis d’établir un lien avec des protéines impliquées dans le contrôle de l’assemblage du fuseau mitotique ainsi que dans le points de contrôle mitotique, étayant ainsi le lien entre le stress réplicatif et les défauts mitotiques. Pour finir, l’immunoprécipitation de la chromatine liée à la protéine pRPA-Ser33 en phase G2, suivie d’un séquençage (ChIPseq), a permis de révéler l’absence d’enrichissement au niveau des sites fragiles communs et de mettre en évidence un enrichissement au niveau des régions promotrices de certains gènes, notamment de gènes impliqués dans la régulation du cycle cellulaire et de la mort cellulaire. Ces résultats soulignent le lien entre le stress réplicatif très faible ou endogène et l’instabilité chromosomique, qui peut mener à l’initiation tumorale. / DNA replication is a physiological process, essential for genetic information transmission but DNA replication is also an important source of endogenous stress. Replicative stress can lead to genomic instability and has been reported in early-stage malignancies and senescence. Homologous recombination is a repair process which can handle replicative stress. Therefore, a defect in homologous recombination could reveal endogenous replicative stresses. Consistently, a slow down in replication fork progression has been observed in homologous recombination deficient (HR-) cells, in absence of any exogenous treatment (Daboussi et al. 2008). In addition, several studies have shown the presence of mitotic defects in HR- cells, in absence of any exogenous treatment (Griffin 2000; Kraakman-van der Zwet 2002; Bertrand 2003; Daboussi 2005; Laulier et al. 2011; Rodrigue 2013). The origin of these spontaneous mitotic defects is still unclear. Indeed, homologous recombination is preferentially active in S and G2 phases thus, the link with mitosis remains to be elucidated. The aim of this thesis is to understand the impact of a low or endogenous replicative stress on post-replicative phases. First, I studied the impact of a low or endogenous replicative stress on mitosis. Control cells were treated with very low hydroxyurea doses, that did not affected cell cycle progression but did slow down the replication fork progression to the same level than unchallenged HR- cells. Importanntly, exposure of the control cells to these low hydroxyurea doses generated the same mitotic defects, notably extra centrosomes, and to the same extent than in untreated HR- cells. Reciprocally, supplying nucleotide precursors to HR- cells suppressed both their replication deceleration and mitotic extra centrosome phenotypes. Therefore, subtle replication stress that does not impact S and G2 phase progression nor the entry in mitosis, nevertheless causes severe mitotic defects. Importantly, mitotic extra centrosome can lead to multipolar mitosis and then impact the whole genome stability. These data highlight the crosstalk between chromosome replication and segregation. Secondly, I studied the impact of low or endogenous replicative stress on G2 phase. This study was done using HR- cells as well as control cells treated with very low HU doses to induce a very low replicative stress. In both of these models, the presence of pRPA-Ser33 foci was observed in G2 phase, highlighting replicative stress regions. After very low HU treatement, we observed 53BP1 and RAD51 foci in G2 phase. These foci partially colocalized with pRPA-Ser33 foci in G2 phase. Mass spectrometry analyse after 53BP1 coimmunoprecipitation allowed to etablish a link between proteins involved in mitotic spindle assembly control and in mitotic checkpoint. These data support the link between replicative stress and mitotic defects. Lastly, the immmunoprecipitation of the chromatin interacting with pRPA-Ser33 in G2 phase, followed by sequencing (ChIPseq) allowed to reveal the absence of common fragile site enrichment and to highlight an enrichment at promoter regions of genes involved in cell cycle and cell death regulation. These data underline the link between very low or endogenous replicative stress and chromosomal instability, which can lead to tumorigenesis.

Human pluripotent stem cells are increasingly used for cell-based regenerative therapies worldwide, with the use of embryonic and induced pluripotent stem cells as potential treatments for a range of debilitating and chronic conditions. However, with the level of chromosomal aneuploidies the cells may generate in culture, their safety for therapeutic use could be in question. This study aimed to develop sensitive and high-throughput assays for the detection and quantification of human pluripotent stem cell aneuploidies, to assess any changes in their positioning in nuclei, as well as investigate the possible roles of lamins in the accumulation of aneuploidies. Using Droplet Digital PCR™, we optimised the detection of aneuploid cells in a predominantly diploid background. An assay was established for the sensitive detection of up to 1% of mosaicism and was used for the monitoring of low-level chromosome copy number changes across different cell lines, conditions and passages in the human pluripotent stem cells. In addition, fluorescence in-situ hybridisation was used to map genes ALB and AMELX on chromosomes 4 and X, respectively, in karyotype-stable chromosome X aneuploid lymphoblastoid cell lines. Our results demonstrated significant alternations in the gene loci positioning in the chromosome X aneuploid cell lines. Using the same established method, the positioning of ALB and AMELX was monitored, alongside the genomic instability with ddPCR™, in the different human pluripotent stem cell lines, conditions and passage. We demonstrated a highly plastic nuclear organisation in the pluripotent stem cells with many changes occurring within a single passage. Furthermore, these results were not exclusive to a single cell line or condition, regardless of the presence or absence of feeder cells and of passage number, and the flexibility of the chromatin organisation remained throughout the duration of the study. We demonstrated high levels of genomic instability with recurrent gains and losses in the AMELX copy number in the human embryonic stem cells during the course of our study, however no significant changes in their gene loci positioning from these abnormalities were observed. xvi | P a g e Additionally, we observed reduced levels of lamin B2 in the aneuploid lymphoblastoid cell lines and complete loss in some hPSC samples. Our results support recent findings that suggest a link between lamin B2 loss and the formation of chromosome aneuploidies in cell culture. In conclusion, our data demonstrates several key novel findings. Firstly, we have established a sensitive technique for the detection of up to 1% mosaicism, which to our knowledge is the most sensitive assay currently available. Secondly, we showed significant changes in the gene loci positioning between aneuploid and diploid cell lines. Thirdly, utilising our novel ddPCR™ assay, we demonstrated the karyotypical instability of hPCSs with consistent gains and/or loses of gene copy numbers in a short period of time in culture. When studying the effects of different growth conditions, we showed that the karyotypical instability was not exclusive to a single condition or a combination of conditions, and what is more, the karyotypical abnormalities detected were not observed to change the gene positioning of hPSCs significantly, with the genome organisation remaining plastic. Finally, our results support a potential association of lamin B2 loss and karyotypical instability. We conclude that more sensitive and robust techniques need to be readily used by clinicians for the screening of potential therapeutic hPSCs.